We are thrilled to announce our strategic partnership with Foundation Medicine to enhance clinical trial recruitment and expand access to precision cancer care. This collaboration combines Massive Bio's AI-driven trial matching technology with Foundation Medicine’s genomic profiling expertise. Together, we aim to significantly improve clinical trial enrollment rates. Dr. Arturo LoAIza-Bonilla MD, Co-founder and Chief Medical Officer, emphasizes the transformative potential: "Our combined technologies will accelerate patient access to personalized treatments, changing the landscape of cancer care." For more information about this groundbreaking partnership and its impact on oncology, visit our website at https://lnkd.in/dc_UzyEx Together, we are setting new standards in the field, ensuring advanced therapies reach patients faster and more efficiently. 🌐🔍 #MassiveBio #FoundationMedicine #Oncology #CancerTreatment #AIinHealthcare Selin Kurnaz, PhD, Çağatay M. Çulcuoğlu, Arturo LoAIza-Bonilla MD
Massive Bio
Hospitals and Health Care
New York, NY 23,603 followers
An AI-driven platform connecting cancer patients to bio-pharmaceutical clinical trials.
About us
Increasing Accessibility to Clinical Trials and Personalized Cancer Treatment Options. Every cancer patient is different and deserves treatment of the highest quality that is personalized, affordable, and easily accessible. Massive Bio translates the world-class oncology knowledge of the large cancer centers' experts, facilitates a virtual tumor board collaboratively with the treating oncologist, and advises the patient and treating oncologist to operationalize these expert recommendations at the point of care thereby, eliminating additional time, travel, and cost. 85% of US cancer patients receive treatments in community practices where treating oncologists are overwhelmed with the influx of new tests and treatments while trying to manage their busy practices. We believe all cancer patients deserve equal access to the latest in cancer research and treatment.
- Website
-
https://linktr.ee/massivebio_
External link for Massive Bio
- Industry
- Hospitals and Health Care
- Company size
- 51-200 employees
- Headquarters
- New York, NY
- Type
- Privately Held
- Founded
- 2014
- Specialties
- Targeted cancer therapies, Cancer genomics, Tumor profiling technologies, Clinical trial selection, Second Opinion, Cancer Treatment, precision oncology, personalized cancer treatment options, Oncology, Cancer Care, and Cancer Research
Locations
-
Primary
90 West St
New York, NY 10006, US
Employees at Massive Bio
Updates
-
Day three at ESMO 2024 is in full swing, and our booth is buzzing with energy! ⚡ At Massive Bio, we’re excited to showcase how our innovative technology is transforming cancer care. From groundbreaking clinical trials to personalized treatment strategies, we're eager to connect with passionate professionals dedicated to advancing oncology. Our products are leading the way in reshaping cancer care, and we’re excited to share all the latest developments. If you’re attending ESMO, don’t miss the chance to visit us at booth #431. Massive thanks to Mert Sari, Our Director for OUS Provider Engagement, and Gisela Saladino, our Account Manager for Spain, for sharing their insights and engage with attendees. Massive Bio is at ESMO 2024: https://lnkd.in/dKQwsHZF #ESMO2024 #Oncology #Innovation #AIinHealthcare Selin Kurnaz, PhD, Çağatay M. Çulcuoğlu, Arturo LoAIza-Bonilla MD
-
Our team is proud to be on the ground at ESMO 2024, engaging with oncology experts and fostering conversations that drive innovation in cancer care. Stop by Booth #431 to discover how we are simplifying access to breakthrough therapies and research. Together, we’re making strides to shape a brighter future in oncology. Special shoutout to Oz Huner, our VP, Head of Product, and Gisela Saladino, our Account Manager for Spain, for their dedication at this important event! Learn more: https://lnkd.in/duttTzp9 #ESMO2024 #OncologyInnovation #MassiveBio Selin Kurnaz, PhD, Çağatay M. Çulcuoğlu, Arturo LoAIza-Bonilla MD, Oz Huner, Gisela Saladino
-
Our team is actively engaging with professionals from around the world at the #ESMO 2024 Congress. This prestigious event is a key opportunity to share knowledge, foster collaborations, and explore the latest breakthroughs in oncology. We’re proud to be part of these important discussions that are shaping the future of cancer care. Visit us at Booth #431 to connect with us and learn more about our innovative approaches in oncology. Massive Bio is at ESMO 2024: https://lnkd.in/dKQwsHZF #ESMO2024 #OncologyInnovation #MassiveBio Selin Kurnaz, PhD, Çağatay M. Çulcuoğlu, Arturo LoAIza-Bonilla MD
-
Exciting preparations underway for ESMO Congress 2024! Our Co-founder, CTO & COO Çağatay M. Çulcuoğlu, and Chief Product Officer Oz Huner are leading the charge as we gear up for this major event. Don't forget to visit us at Booth #431. Learn more: massivebio.com/esmo/ #ESMO2024 #Oncology #ESMO #OncologyInnovation Selin Kurnaz, PhD, Çağatay M. Çulcuoğlu, Arturo LoAIza-Bonilla MD
-
The #ESMO Congress 2024 is a great opportunity for Massive Bio to connect with the oncology community. Meet our co-founders at Booth #431 to discuss patient enrollment challenges and learn about our innovative, AI-powered solutions. Also, we're excited to join the OncoDaily Party and meet professionals from around the world! Don’t miss the chance to meet the Massive Bio team and discover how we're shaping the future of oncology. Learn more: https://lnkd.in/dKQwsHZF #ESMO2024 #OncologyInnovation #MassiveBio #OncoDaily Selin Kurnaz, PhD, Çağatay M. Çulcuoğlu, Arturo LoAIza-Bonilla MD
-
Massive Bio reposted this
We’re thrilled to spotlight the incredible companies advancing Health Equity through digital innovation! 🙌 These quarterfinalists for the Digital Health Hub Foundation Awards are leading the charge in creating solutions that improve access, outcomes, and care for all communities, addressing critical disparities in health. Congratulations to all the companies that have made it this far! Stay tuned as we continue the journey to find the Best in Class for 2024. Congratulations to: Massive Bio MEDICAL IP Proximie iPLATO - a Huma Company Buymed Sword Health Upfront Healthcare Lumeris Homeward Cylinder Hint Health Hawthorne Health, Inc. Lightbeam Health Solutions Uno Health Inovalon
-
Today, we remember the lives lost on September 11, 2001, and honor the bravery and resilience shown by so many on that day. It's a time for reflection, unity, and remembrance. May we never forget the strength that arose from the tragedy and continue to carry that spirit of compassion and solidarity forward. Selin Kurnaz, PhD, Çağatay M. Çulcuoğlu, Arturo LoAIza-Bonilla MD
-
Massive Bio is excited to support CancerX Moonshot in the launch of two powerful tools: the Digital Navigation ROI Calculator and the Patient Navigation Blueprint. These resources are designed to help health systems reduce financial barriers in cancer care by optimizing their investments in patient navigation. As a leader in AI-driven cancer care and clinical trial matching, Massive Bio is proud to be part of this mission to minimize disparities and improve cancer outcomes through digital innovation. Learn more about Massive Bio: massivebio.com #CancerCare #DigitalInnovation #MassiveBio #CancerX #ClinicalTrials #PatientEquity Selin Kurnaz, PhD, Çağatay M. Çulcuoğlu, Arturo LoAIza-Bonilla MD
-
🌟 Employee Spotlight: Kristina, Last Mile Nurse Navigator 🌟 We're excited to highlight Kristina Hine, our dedicated Last Mile Nurse Navigator at Massive Bio. Kristina is the key support for our patients, guiding them through every step of their clinical trial journey. Her role focuses on removing barriers—be they logistical, financial, or social—ensuring each patient has access to life-saving treatments. Kristina is inspired by our innovative approach to healthcare, using AI and data analytics to connect patients with the best clinical trials. Working with a team that shares her commitment to enhancing patient outcomes gives her a deep sense of purpose. Thank you, Kristina, for your exceptional dedication and impact on patient care! #employeespotlight #cancercare #cancerclinicaltrial Selin Kurnaz, PhD, Çağatay M. Çulcuoğlu, Arturo LoAIza-Bonilla MD